137 related articles for article (PubMed ID: 1826724)
1. Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG.
Ben-Rafael Z; Bider D; Dan U; Zolti M; Levran D; Mashiach S
J In Vitro Fert Embryo Transf; 1991 Feb; 8(1):33-6. PubMed ID: 1826724
[TBL] [Abstract][Full Text] [Related]
2. Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels.
Ben-Rafael Z; Lipitz S; Bider D; Mashiach S
Fertil Steril; 1991 Feb; 55(2):272-5. PubMed ID: 1825069
[TBL] [Abstract][Full Text] [Related]
3. The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).
Gonen Y; Dirnfeld M; Goldman S; Koifman M; Abramovici H
J In Vitro Fert Embryo Transf; 1991 Oct; 8(5):254-9. PubMed ID: 1836810
[TBL] [Abstract][Full Text] [Related]
4. The impact of the refractory period to gonadotropin therapy in IVF-ET cycles post longacting gonadotropin-releasing hormone (GNRH) analogue.
Ashkenazi J; Goldman GA; Dicker D; Feldberg D; Shelef M; Goldman JA
Eur J Obstet Gynecol Reprod Biol; 1991 Mar; 39(1):37-40. PubMed ID: 1827627
[TBL] [Abstract][Full Text] [Related]
5. Ovarian response and pregnancy rates in in vitro fertilization, gamete intrafallopian transfer, and in vivo fertilization therapies after combined gonadotropin-releasing hormone agonist/human menopausal gonadotropin stimulation.
Lindner C; Braendle W; Lichtenberg V; Köhler S; Bettendorf G
Gynecol Obstet Invest; 1990; 29(2):140-4. PubMed ID: 2139861
[TBL] [Abstract][Full Text] [Related]
6. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
[TBL] [Abstract][Full Text] [Related]
7. The use of gonadotropin releasing hormone agonist (GnRHa) in good responders undergoing repeat in vitro fertilization/embryo transfer (IVF/ET).
Segars JH; Hill GA; Bryan SH; Herbert CM; Osteen KG; Rogers BJ; Wentz AC
J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):327-31. PubMed ID: 2127603
[TBL] [Abstract][Full Text] [Related]
8. The use of a long-acting gonadotropin-releasing hormone analog(D-Trp-6-LHRH) for improvement of ovarian stimulation in assisted conception programs.
Yang YS; Ho HN; Lien YR; Hwang JL; Melinda S; Lin HR; Lee TY
J Formos Med Assoc; 1991 Nov; 90(11):1081-5. PubMed ID: 1687055
[TBL] [Abstract][Full Text] [Related]
9. Good results of milder form of ovarian stimulation in an in vitro fertilization/intracytoplasmic sperm injection program.
Grochowski D; Wołczyński S; Kuczyński W; Domitrz J; Szamatowicz J; Szamatowicz M
Gynecol Endocrinol; 1999 Oct; 13(5):297-304. PubMed ID: 10599545
[TBL] [Abstract][Full Text] [Related]
10. [Increased incidence of ovarian hyperstimulation syndrome following combined GnRH agonist/hMG therapy].
Lindner C; Braendle W; Köhler S; Bettendorf G
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):337-44. PubMed ID: 2525500
[TBL] [Abstract][Full Text] [Related]
11. The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.
Younis JS; Simon A; Koren R; Dorembus D; Schenker JG; Laufer N
Fertil Steril; 1992 Sep; 58(3):575-80. PubMed ID: 1387849
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.
Herman A; Ron-El R; Golan A; Raziel A; Soffer Y; Caspi E
Fertil Steril; 1990 Jan; 53(1):92-6. PubMed ID: 2104811
[TBL] [Abstract][Full Text] [Related]
13. Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase--a function of improved embryo quality.
Schachter M; Friedler S; Raziel A; Strassburger D; Bern O; Ron-el R
J Assist Reprod Genet; 2001 Apr; 18(4):197-204. PubMed ID: 11432110
[TBL] [Abstract][Full Text] [Related]
14. Ovarian response in repetitive cycles induced by menotrophin alone or combined with gonadotrophin releasing hormone analogue.
Ron-El R; Raziel A; Herman A; Golan A; Nahum H; Soffer Y; Caspi E
Hum Reprod; 1990 May; 5(4):427-30. PubMed ID: 2141846
[TBL] [Abstract][Full Text] [Related]
15. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
[TBL] [Abstract][Full Text] [Related]
16. Performance of cryopreserved pre-embryos obtained in in vitro fertilization cycles with or without a gonadotropin-releasing hormone agonist.
Oehninger S; Toner JP; Veeck LL; Brzyski RG; Acosta AA; Muasher SJ
Fertil Steril; 1992 Mar; 57(3):620-5. PubMed ID: 1740208
[TBL] [Abstract][Full Text] [Related]
17. GnRH agonist increases pregnancy potential of retrieved oocytes given adequate preincubation before insemination: a comparative study.
Feldberg D; Goldman GA; Dicker D; Ashkenazi J; Shelef M; Goldman JA
Eur J Obstet Gynecol Reprod Biol; 1991 Apr; 39(2):111-6. PubMed ID: 1828775
[TBL] [Abstract][Full Text] [Related]
18. Midluteal gonadotropin-releasing hormone analog administration in early pregnancy.
Ron-El R; Golan A; Herman A; Raziel A; Soffer Y; Caspi E
Fertil Steril; 1990 Mar; 53(3):572-4. PubMed ID: 2137797
[TBL] [Abstract][Full Text] [Related]
19. Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol.
Orvieto R; Volodarsky M; Hod E; Homburg R; Rabinson J; Zohav E; Anteby EY; Meltcer S
Gynecol Endocrinol; 2007; 23(8):494-6. PubMed ID: 17852411
[TBL] [Abstract][Full Text] [Related]
20. Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women.
Hugues JN; Torresani T; Herve F; Martin-Pont B; Tamboise A; Santarelli J
Fertil Steril; 1991 May; 55(5):945-51. PubMed ID: 1827076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
